Please login to the form below

Not currently logged in
Email:
Password:

Acquisition

This page shows the latest Acquisition news and features for those working in and with pharma, biotech and healthcare.

Lundbeck bolts on migraine drug via $1.95bn deal to buy Alder

Lundbeck bolts on migraine drug via $1.95bn deal to buy Alder

up. The acquisition of Alder comes after Lundbeck bought  Abide Therapeutics for $400m earlier this year – adding mid-stage drug candidate ABX-1431 for Tourette’s syndrome – and last year’s

Latest news

More from news
Approximately 189 fully matching, plus 1,141 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 73 fully matching, plus 82 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 116 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 8 fully matching, plus 61 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Nobull Communications

Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...

Latest intelligence

Alzheimers incidence
A roadmap to the successful treatment of Alzheimer’s disease
Building on past research to learn more about the disease and how to treat it...
Article: Like, Like, Like: Harnessing the power of social media insights
...
Its Know Your Numbers week
Do you know yours?...

Infographics